Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. EVCM

(EVCM)

0.00

0.00 (0.00%)

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
These 16 stocks are a short seller's dream — likely losers no matter what the market does
27.03.2026

These 16 stocks are a short seller's dream — likely losers no matter what the market does

Borrowing costs eat into trading profits. These stocks are less expensive to short.

EverCommerce Stock: Is There a Path to a $12 Price Target?
13.03.2026

EverCommerce Stock: Is There a Path to a $12 Price Target?

EverCommerce (NASDAQ:EVCM) has had a volatile stretch.

EverCommerce Inc. (EVCM) Q4 2025 Earnings Call Transcript
12.03.2026

EverCommerce Inc. (EVCM) Q4 2025 Earnings Call Transcript

EverCommerce Inc. (EVCM) Q4 2025 Earnings Call Transcript

EverCommerce (EVCM) Misses Q4 Earnings Estimates
12.03.2026

EverCommerce (EVCM) Misses Q4 Earnings Estimates

EverCommerce (EVCM) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.07 per share a year ago.

EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results
12.03.2026

EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results

DENVER, March 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, announced today financial results for the quarter and year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue from continuing operations of $151.2 million, an increase of 5.2% compared to $143.7 million for the quarter ended December 31, 2024.

DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution
10.03.2026

DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution

EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EverCommerce Inc. – EVCM
03.03.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EverCommerce Inc. – EVCM

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of EverCommerce Inc. (“EverCommerce” or the “Company”) (NASDAQ: EVCM). Such investors are advised to contact Danielle Peyton at  [email protected]  or 646-581-9980, ext. 7980.

Videos

No Data

There is no data to display

Press releases

EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results
12.03.2026

EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results

DENVER, March 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, announced today financial results for the quarter and year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Revenue from continuing operations of $151.2 million, an increase of 5.2% compared to $143.7 million for the quarter ended December 31, 2024.

DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution
10.03.2026

DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution

EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EverCommerce Inc. – EVCM
03.03.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EverCommerce Inc. – EVCM

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of EverCommerce Inc. (“EverCommerce” or the “Company”) (NASDAQ: EVCM). Such investors are advised to contact Danielle Peyton at  [email protected]  or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EverCommerce Inc. - EVCM
26.02.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EverCommerce Inc. - EVCM

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.